LBRX

LB Pharmaceuticals Inc Common Stock

There isn't enough reported data to score LBRX yet.

LBRX Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Unavailable

There isn't enough reported data to rate LBRX's fundamentals.

LBRX PE Valuation

LBRX has no meaningful PE right now: it lost money over the past year.

LBRX Forward outlook

MetricOutlook
--
Losses growing
--
--
Limited
Moderate

Analysts expect LBRX's losses to grow, with revenue holding steady.

LBRX Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $42.46 on Nov 12.

There is not enough scenario data to assess LBRX's risk to reward.

LBRX Earnings Per Share

LBRX Quarterly Revenue

Q1 2024: $0Q2 2024: $0Q3 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q1 2024: $0Q2 2024: $0Q3 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

LBRX Free Cash Flow

Q1 2024: −$10MQ2 2024: −$16MQ3 2024: −$22MQ1 2025: −$8MQ2 2025: −$6MQ3 2025: --Q4 2025: −$18MQ1 2026: −$23MQ2 2026: −$38MQ3 2026: −$64M
Q1 2024: −$10MQ2 2024: −$16MQ3 2024: −$22MQ1 2025: −$8MQ2 2025: −$6MQ3 2025: --Q4 2025: −$18MQ1 2026: −$23MQ2 2026: −$38MQ3 2026: −$64M
QuarterFree cash flowYoY
Q2 2026-$38M-$32.4M
Q1 2026-$23.3M-$15.2M
Q2 2025-$5.6M+$10.2M
Q1 2025-$8.1M+$1.5M

LBRX has burned cash in almost every quarter: −$144M over the past year, against −$52M the year before.

LBRX Total Shares

Q1 2025: 251,789Q2 2025: 251,789Q3 2025: 6MQ1 2026: 28MQ2 2026: 30MQ3 2026: 33M
Q1 2025: 251,789Q2 2025: 251,789Q3 2025: 6MQ1 2026: 28MQ2 2026: 30MQ3 2026: 33M
PeriodChange %Net change
Quarterly+9.8%+2.9M shares
1 year+13038%+32.8M shares

LBRX has 33M diluted shares, up 13038% from a year ago.

LBRX Net Leverage

LBRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

LBRX Weekly Momentum

MetricValueStatus
RSI61.0Neutral
Stochastic48.5Neutral

LBRX's weekly RSI is 61 (neutral) and its Stochastic is 49 (neutral).

LBRX PE vs Healthcare Sector

LBRX has no meaningful PE right now: it lost money over the past year.

LBRX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$38.99.2% above
20 week MA$40.64.6% above
50 week MA$31.435% above

LBRX is in an uptrend: it's above all three of its weekly moving averages, and 35% above its 50-week average.

LBRX Yearly ROI

YearStart priceEnd priceROI
2025$16.8$21.5+28%
2026 YTD$21.5$42.5+97%

LBRX has finished every year since 2025 higher, and it's up 97% so far in 2026.

Give your agent the market.

Get API key